Journal of Antimicrobial Chemotherapy (2000) 46, 273-277
© 2000 The British Society for Antimicrobial Chemotherapy
Brief reports |
Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae
a Department of Biology, Area of Microbiology and IMEDEA-CSIC, University of the Balearic Islands, b Department of Microbiology, School of Medicine, University of Seville and c Department of Microbiology, School of Biology, University of Barcelona, Spain
The activities of ß-lactams, chloramphenicol, tetracycline, fluoroquinolones and aminoglycosides against Klebsiella pneumoniae C3 (O1:K66, producing porins OmpK35 and OmpK36) and a set of isogenic mutants derived from it lacking the O antigen of lipopolysaccharide (LPS), capsular K antigen, or one or both porins were determined. MICs remained within one dilution step in mutants deficient in antigen O, in capsule or in one of the two porins. No increases in the MICs of aminoglycosides, fluoroquinolones, tetracycline and chloramphenicol were observed for strains deficient in the two porins, but the MICs of ampicillin, cephalothin, cefoxitin, cefotaxime and ceftazidime for this type of mutant increased four- to >256-fold. The highest MICs of ß-lactams were obtained in a porin-deficient mutant expressing increased ß-lactamase activity. It is concluded that isolated outer membrane alterations in K. pneumoniae are not decisive factors in increasing resistance to antimicrobial agents, but porin loss co-operates with ß-actamase production to increase resistance to ß-lactams.
* Correspondence address. Department of Microbiology, School of Medicine, Apdo. 914, 41080 Seville, Spain. Tel: +34-95-4557448; Fax: +34-95-4377413; E-mail: lmartin{at}cica.es
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
O. Danilchanka, C. Mailaender, and M. Niederweis Identification of a Novel Multidrug Efflux Pump of Mycobacterium tuberculosis Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2503 - 2511. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Y Tan, S Y Ng, L Teo, Y Koh, and C H Teok Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis J. Clin. Pathol., May 1, 2008; 61(5): 642 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Kaczmarek, F. Dib-Hajj, W. Shang, and T. D. Gootz High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of blaACT-1 {beta}-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE. Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3396 - 3406. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Lee, J.-H. Chia, C. Chu, T.-L. Wu, J.-W. Liu, and L.-H. Su In vivo selection of OmpK35-deficient mutant after cefuroxime therapy for primary liver abscess caused by Klebsiella pneumoniae J. Antimicrob. Chemother., October 1, 2006; 58(4): 857 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mena, V. Plasencia, L. Garcia, O. Hidalgo, J. I. Ayestaran, S. Alberti, N. Borrell, J. L. Perez, and A. Oliver Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development. J. Clin. Microbiol., August 1, 2006; 44(8): 2831 - 2837. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Jacoby, K. E. Walsh, and V. J. Walker Identification of Extended-Spectrum, AmpC, and Carbapenem- Hydrolyzing {beta}-Lactamases in Escherichia coli and Klebsiella pneumoniae by Disk Tests. J. Clin. Microbiol., June 1, 2006; 44(6): 1971 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Black, K. S. Thomson, J. D. Buynak, and J. D. D. Pitout Evaluation of {beta}-Lactamase Inhibitors in Disk Tests for Detection of Plasmid-Mediated AmpC {beta}-Lactamases in Well-Characterized Clinical Strains of Klebsiella spp. J. Clin. Microbiol., August 1, 2005; 43(8): 4168 - 4171. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nikaido Molecular Basis of Bacterial Outer Membrane Permeability Revisited Microbiol. Mol. Biol. Rev., December 1, 2003; 67(4): 593 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Nelson, H. Segal, and B. G. Elisha Outer membrane protein alterations and blaTEM-1 variants: their role in {beta}-lactam resistance in Klebsiella pneumoniae J. Antimicrob. Chemother., December 1, 2003; 52(6): 899 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Domenech-Sanchez, L. Martinez-Martinez, S. Hernandez-Alles, M. del Carmen Conejo, A. Pascual, J. M. Tomas, S. Alberti, and V. J. Benedi Role of Klebsiella pneumoniae OmpK35 Porin in Antimicrobial Resistance Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3332 - 3335. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gayet, R. Chollet, G. Molle, J.-M. Pages, and J. Chevalier Modification of Outer Membrane Protein Profile and Evidence Suggesting an Active Drug Pump in Enterobacter aerogenes Clinical Strains Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1555 - 1559. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Martinez-Martinez, A. Pascual, M. d. C. Conejo, I. Garcia, P. Joyanes, A. Domenech-Sanchez, and V. J. Benedi Energy-Dependent Accumulation of Norfloxacin and Porin Expression in Clinical Isolates of Klebsiella pneumoniae and Relationship to Extended-Spectrum {beta}-Lactamase Production Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3926 - 3932. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Olesky, M. Hobbs, and R. A. Nicholas Identification and Analysis of Amino Acid Mutations in Porin IB That Mediate Intermediate-Level Resistance to Penicillin and Tetracycline in Neisseria gonorrhoeae Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2811 - 2820. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Philippon, G. Arlet, and G. A. Jacoby Plasmid-Determined AmpC-Type {beta}-Lactamases Antimicrob. Agents Chemother., January 1, 2002; 46(1): 1 - 11. [Full Text] [PDF] |
||||
![]() |
L. K. Siu, J. K. Rasheed, L. Martínez-Martínez, and G. A. Jacoby Is OmpK35 Specific for Ceftazadime Penetration? Antimicrob. Agents Chemother., May 1, 2001; 45(5): 1601 - 1602. [Full Text] |
||||




